Share Prices & Company Research

Market News

05 Feb 2021 | 14:55

EU's Borrell call for Sputnik V vaccine to be approved

(Sharecast News) - EU's foreign policy chief Josep Borrell said on Friday that the Russain state-developed Covid-19 jab called Sputnik V should be approved by the bloc. Borrell, who was the first senior EU official visiting Moscow since 2017, said confirmation of the high efficacy of Russia's Sputnik V vaccine was "good for all mankind, it means we will have more tools to fight the pandemic."

"I hope that now the European Medicines Agency will be able to certify this vaccine for use in the EU member states," he told reporters.

"This will be good news for us, because, as you know, we do not have enough vaccines and an additional source of their supply is only welcome. Congratulations again on the success of Russian scientists."

The European Commission is under strain due to its problems securing sufficient jabs to distribute and was recently embroiled in a dispute with AstraZeneca after the drug giant unexpectedly announced that it would ship fewer than expected vaccines to the bloc.

Sputnik V was found to have an efficacy of 91.6%.

Hungary is the only EU country that has approved the vaccine so far and only on an emergency use basis.

Borrell was visiting Moscow just two days after Russian activist Alexei Navalny was sentenced to a more than two year prison sentence, amid protests by his supporters which resulted in a crackdown by police.

The EU's diplomatic chief had asked the Kremlin for Navalny's release and a full investigation into his attempted assassination last August.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 14th May 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.